Anti-XDR-TB drug, anti-MDR-TB drug, and combination anti-tuberculosis drug
US9040502B2 · kind B2 · utility
0Cited by
2References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 30, 2011 |
| Grant date | May 26, 2015 |
| Priority date | — |
| Expiry date | Feb 6, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating an individual infected with XDR-TB, the method including administering to the individual an anti-XDR-TB drug which comprises a compound having a structure expressed by Structural Formula (1) below:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.